AKUS Overview
Upcoming Projects (AKUS)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (AKUS)
-
Discussing the potential of Regeneron's otoferlin gene therapy, currently being investigated in the Phase 1/2 CHORD trial for patients with genetic hearing loss
Tickers: REGN, AKUS, LLY
Executed On: Dec 13, 2023 at 01:00 PM EST
Upcoming & Overdue Catalysts (AKUS)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (AKUS)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
